TABLE 3.
CT scores of patients in each lung lobe.
| Early stage | Progressive and peak stage | Absorption stage | ||
|---|---|---|---|---|
| Right upper lobe | Delta Variant | 0.5 ± 0.5 (0–2) | 0.8 ± 0.6 (0–3) | 0.7 ± 0.7 (0–3) |
| Original COVID-19 | 0.8 ± 0.7 (0–1) | 1.0 ± 0.4 (0–2) | 0.6 ± 0.6 (0–2) | |
| Right middle lobe | Delta Variant | 0.5 ± 0.5 (0–2) | 0.8 ± 0.7 (0–4) | 0.6 ± 0.7 (0–4)* |
| Original COVID-19 | 0.5 ± 0.5 (0–1) | 0.8 ± 0.7 (0–2) | 0.3 ± 0.4 (0–1)* | |
| Right lower lobe | Delta Variant | 0.8 ± 0.6 (0–2)* | 1.2 ± 0.9 (0–4) | 0.9 ± 0.8 (0–4) |
| Original COVID-19 | 1.3 ± 0.6 (0–2)* | 1.4 ± 0.5 (1–2) | 0.8 ± 0.7 (0–3) | |
| Left upper lobe | Delta Variant | 0.7 ± 0.4 (0–2) | 1.0 ± 0.7 (0–4) | 0.9 ± 0.8 (0–4)* |
| Original COVID-19 | 0.6 ± 0.5 (0–1) | 0.6 ± 0.4 (0–1) | 0.5 ± 0.5 (0–2)* | |
| Left lower lobe | Delta Variant | 1.2 ± 0.8 (0–4) | 1.4 ± 0.8 (0–4) | 1.2 ± 0.9 (0–4) |
| Original COVID-19 | 1.4 ± 0.5 (1–2) | 1.3 ± 0.6 (0–2) | 1.1 ± 0.7 (0–4) |
Data are means ± standard deviations, with ranges in parentheses.
*Represents significant difference obtained by Mann–Whitney U test (p < 0.05).